Comighod, Hanna .
HRN: 22-26-92 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/26/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/26/2024
12/03/2024
IV
900mg
Q6
UTI
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Urinary TractBloodstreamProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes